Related Experiment Video
Updated: Feb 14, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Contraindications to intravenous rtPA for acute stroke: A critical reappraisal
Jennifer E Fugate1, Alejandro A Rabinstein1
1Division of Critical Care Neurology, Mayo Clinic, Rochester, MN.
Abstract:
Only 1%-5% of patients with acute ischemic stroke presenting within 3 hours of symptoms receive IV recombinant tissue plasminogen activator (rtPA)-the only effective treatment available. The administration of rtPA is limited by extensive exclusion criteria, many of which are not based on evidence, but rather derived from expert opinion for large stroke trials. Over the past 15 years, experiences with the use of rtPA in clinical practice have led to evidence suggesting that several of the current contraindications for rtPA are unnecessary and overly restrictive. In this review, we analyze the evidence-most of which is derived from observational research-supporting or contradicting current contraindications for administering IV rtPA to acute ischemic stroke patients.
Related Concept Videos
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
Critical Values
Critical Thinking
Colleges and universities are...
Critical Thinking I
Critical Thinking II
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...

